Q3 2023 Earnings Forecast for Iovance Biotherapeutics, Inc. Issued By HC Wainwright (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) – Research analysts at HC Wainwright cut their Q3 2023 earnings per share estimates for shares of Iovance Biotherapeutics in a research report issued to clients and investors on Wednesday, August 16th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will post earnings of ($0.48) […]

Related Keywords

Stifel Nicolaus ,Iovance Biotherapeutics ,Iovance Biotherapeutic ,Wells Fargo Company ,Perceptive Advisors ,Nasdaq ,Fund Management ,Morgan Stanley ,Blackrock Inc ,Iovance Biotherapeutics Inc ,Free Report ,Wells Fargo ,Get Free Report ,Street Corp ,Nasdaq Iova ,Tiova ,Medical ,Earnings Estimates ,Hc Wainwright ,